This move is archived. Current quotes and coverage live on the stock page.
Get AVCR alerts:
Avricore Health Inc's stock is feeling the pressure, dropping over 8% in a single trading session.
In the latest trading session, Avricore Health Inc (AVCR.V) saw its stock price decline by 8.33%, closing at CA$0.06. This significant drop raises questions about the company's current market position and future prospects, especially since there hasn't been any recent news to explain the downturn.
Investor takeaway: Investors should be cautious as Avricore Health's stock faces downward pressure, which might indicate underlying issues despite previous growth milestones.
Advertisement
Avricore Health Inc
AVCR.V
AVCR.V
Avricore Health Inc
WealthAwesomeMarket cap
$6.95M
52W high
$0.10
52W low
$0.04
1W change
+27.27%
Beta
0.32
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on AVCR's historical volatility
30-Day Vol
145.8%
Annualized
90-Day Vol
121.1%
Annualized
Trend (90d)
+31.1%
Annualized drift
90d Mean
C$0.08
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.07 | C$0.04 – C$0.12 |
| 60 trading days | C$0.08 | C$0.04 – C$0.15 |
| 90 trading days | C$0.08 | C$0.03 – C$0.19 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Avricore Health Inc's stock down 8.33% in one day
With a current market cap of CA$7,582,179, the decline raises questions about investor confidence amid ongoing expansion efforts.
Bull case
Avricore Health has shown promise with its HealthTab™ platform, achieving significant milestones and expanding into the UK market. This growth could drive future success.
Bear case
The sharp decline in stock price may reflect investor concerns about the company's ability to maintain its growth trajectory and effectively manage recent financing.
Advertisement
Market Reaction
The 8.33% drop in Avricore Health's stock price comes as a surprise, especially considering the company's recent announcements about its expansion plans in the UK. Without any significant news to explain this downturn, investors may be left speculating about potential issues that could impact the company's growth.
Future Outlook
Despite the recent decline, Avricore Health's efforts to expand its HealthTab™ platform in the UK could ultimately provide a path to recovery. Investors should keep an eye on the company's ability to execute these plans and maintain confidence moving forward. For more insights, check out our detailed analysis on Avricore Health Inc.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
